نتایج جستجو برای: oil adjuvant vaccine

تعداد نتایج: 285981  

Journal: :Vaccine 2011
Luis A Brito Michelle Chan Barbara Baudner Simona Gallorini George Santos Derek T O'Hagan Manmohan Singh

Emulsions have been used to boost immunogenicity of antigens since the discovery of complete Freunds adjuvant. Optimization to reduce reactogenicity of emulsion adjuvants lead to the development of oil in water emulsions based on squalene. MF59 is an oil-in-water emulsion that is a component of an approved influenza product in Europe. Currently MF59 is manufactured from squalene derived from an...

2014
Francesca Mantile Maria Trovato Andrea Santoni Pasquale Barba Simone Ottonello Piergiuseppe De Berardinis Antonella Prisco

The development of active immunotherapy for Alzheimer's disease (AD) requires the identification of immunogens that can ensure a high titer antibody response toward Aβ, while minimizing the risks of adverse reactions. Multimeric protein (1-11)E2 induces a robust and persistent antibody response to Aβ in mice, when formulated in Freund's adjuvant. The goal of this translational study was to eval...

2011
James S. McCarthy Joanne Marjason Suzanne Elliott Paul Fahey Gilles Bang Elissa Malkin Eveline Tierney Hayley Aked-Hurditch Christopher Adda Nadia Cross Jack S. Richards Freya J. I. Fowkes Michelle J. Boyle Carole Long Pierre Druilhe James G. Beeson Robin F. Anders

BACKGROUND In a previous Phase 1/2b malaria vaccine trial testing the 3D7 isoform of the malaria vaccine candidate Merozoite surface protein 2 (MSP2), parasite densities in children were reduced by 62%. However, breakthrough parasitemias were disproportionately of the alternate dimorphic form of MSP2, the FC27 genotype. We therefore undertook a dose-escalating, double-blinded, placebo-controlle...

2015
Yong Taik Lim

Adjuvants can be defined as pharmacological and immunological components that are able to modify and/or enhance antigen-specific immune responses. Based on the interdisciplinary research between immunology and material science/engineering, various vaccine adjuvant materials have been developed. By rational design and engineering of antigen or adjuvant materials, immune-modulatory vaccine system...

2012
Eric M. Vela Mathew A. Buccellato Kevin Tordoff Greg Stark John E. Bigger

BACKGROUND In 1997, highly pathogenic avian influenza (HPAI) viruses caused outbreaks of disease in domestic poultry markets in Hong Kong. The virus has also been detected in infected poultry in Europe and Africa. OBJECTIVE The objective of this study was to determine the efficacy of a heterologous vaccine administered with and without the aluminum hydroxide adjuvant in ferrets challenged wit...

2008
Lowell Miller Kathleen Fagerstone Jeffery Kemp Gary Killian Jack Rhyan

The term “vaccine” has traditionally been associated with establishing immunity (antibodies) to a disease. This immunity is usually developed following administration of killed microorganisms. Disease vaccines typically require 1 to 3 injections, depending on the antigen design and efficacy of the vaccine. The effectiveness of the disease vaccine depends on the immune response developed by the ...

2008
Longsheng Yang Jiabin Xue Fang Wang Yuanliang Hu Deyun Wang Weizhong Xu

The experiments were conducted to determine effects of precocious vaccination compared to the classical schedule of vaccination and of Chinese herbal adjuvant (CHA) on immune response to vaccine against rabbit hemorrhagic disease (RHD) in young rabbits. In experiment 1, five New Zealand rabbits at 30, 35, 40 or 45 days of age were injected with 3 ml of non-adjuvant inactivated vaccine against R...

A. R. Jabbari, G. R. Moazeni Jula

Haemorrhagic septicaemia (HS) vaccine which is prepared in Razi Institute is used in endemic areas ofIran. Aluminum-hydroxide gel was used as adjuvant for preparing this vaccine. Post-vaccinal shock reactionswere the main complaint after use of this vaccine. In a previous study, we could improve the vaccine byalum-precipitation Pasteurella multocida cells and removing the liquid phase. In this ...

2011
Daniel Ansong Kwaku P. Asante Johan Vekemans Sandra K. Owusu Ruth Owusu Naana A. W. Brobby David Dosoo Alex Osei-Akoto Kingsley Osei-Kwakye Emmanuel Asafo-Adjei Kwadwo O. Boahen Justice Sylverken George Adjei David Sambian Stephen Apanga Kingsley Kayan Michel H. Janssens Marc J. J. Lievens Aurelie C. Olivier Erik Jongert Patrice Dubois Barbara M. Savarese Joe Cohen Sampson Antwi Brian M. Greenwood Jennifer A. Evans Tsiri Agbenyega Philippe J. Moris Seth Owusu-Agyei

BACKGROUND The Plasmodium falciparum pre-erythrocytic stage candidate vaccine RTS,S is being developed for protection of young children against malaria in sub-Saharan Africa. RTS,S formulated with the liposome based adjuvant AS01(E) or the oil-in-water based adjuvant AS02(D) induces P. falciparum circumsporozoite (CSP) antigen-specific antibody and T cell responses which have been associated wi...

Journal: :iranian journal of veterinary research 2016
f. mukherjee a. prasad v. s. bahekar s. k. rana l. rajendra

the use of liposome as an adjuvant and a vaccine carrier has been cited previously in the literature. it has also been shown to be effective in enhancing the immunogenicity of vaccine candidates. balb/c mice immunized subcutaneously with outer membrane protein (omp) of brucella abortus s19 vaccine strain entrapped in a commercial cationic liposome (s19-omp-liposome) for vaccine delivery, showed...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید